Akebia Therapeutics, Inc. (NASDAQ:AKBA) Given Average Rating of “Buy” by Brokerages
Shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA – Get Free Report) have been assigned an average rating of “Buy” from the five research firms that are currently covering the company, Marketbeat reports. Four equities research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The […]
Shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA – Get Free Report) have been assigned an average rating of “Buy” from the five research firms that are currently covering the company, Marketbeat reports. Four equities research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The […]
